Type 2 diabetes
Conditions
Interventions
Experimental group:The patients in the experimental group took FMD meal replacement food and normal diet alternately during the four-month trial, and ate FMD meal replacement powder from Monday to Fri
Control group:The control group took meal replacement powder from Monday to Friday of the second week of the month (the dosage was different from the test group), and the normal diet for the rest of t
Sponsors
CR& WISCO General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Meet the WHO diagnostic criteria for type 2 diabetes; male and female subjects aged 18 to 65 years (inclusive); BMI >=28 kg / m2; glycemic control of subjects Good, HbA1c is 7.0 to 10.0% (inclusive), and the weight remains relatively stable, and the weight change is not greater than 10% at least 3 months before being included; the subject can and is willing to use a home glucose meter The blood glucose was measured in time to complete the subject's diary card record.
Exclusion criteria
Exclusion criteria: Exclusion criteria: Participated in other clinical trials within 3 months before enrollment; systolic blood pressure >=180mmHg and / or diastolic blood pressure >=110mmHg during screening visits; regular use of insulin, oral steroids or anti-inflammatory drugs; diagnosis of cardiovascular disease Patients with disease, stroke, gastrointestinal disease, chronic nephritis, hepatobiliary disease, renal vascular disease; pregnant and lactating women; subjects are relatives of investigators of the trial, employees of the hospital, or others related to the trial Personnel; subjects have a major illness or are physically weak, and the investigator's judgment may prevent them from completing this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose;2-hour postprandial blood glucose;Glycated hemoglobin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index;waistline;Triglyceride;Serumtotal cholesterol;High-density lipoprotein cholesterol;Low-density lipoprotein cholesterol;blood pressure; | — |
Countries
China
Contacts
Public ContactXuan Lin
CR& WISCO General Hospital
Outcome results
None listed